# MYRBETRIQ GRANULES
> **NDA213801** · New Drug Application · Sponsor: APGDI · Approved 2021-03-25
## Drug
- **FDA Application Number:** NDA213801
- **Application type:** New Drug Application
- **Brand name:** MYRBETRIQ GRANULES
- **Generic name:** MIRABEGRON
- **Active ingredients:** MIRABEGRON
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APGDI
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2021-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213801)
---
*MORVS · CC0 1.0*